Literature DB >> 16866381

Fibrillation of human insulin A and B chains.

Dong-Pyo Hong1, Atta Ahmad, Anthony L Fink.   

Abstract

Human insulin, which consists of disulfide cross-linked A and B polypeptide chains, readily forms amyloid fibrils under slightly destabilizing conditions. We examined whether the isolated A and B chain peptides of human insulin would form fibrils at neutral and acidic pH. Although insulin exhibits a pH-dependent lag phase in fibrillation, the A chain formed fibrils without a lag at both pHs. In contrast, the B chain exhibited complex concentration-dependent fibrillation behavior at acidic pH. At higher concentrations, e.g., >0.2 mg/mL, the B chains preferentially and rapidly formed stable protofilaments rather than mature fibrils upon incubation at 37 degrees C. Surprisingly, these protofilaments did not convert into mature fibrils. At lower B chain concentrations, however, mature fibrils were formed. The explanation for the concentration dependence of B chain fibrillation is as follows. The B chains exist as soluble oligomers at acidic pH, have a beta-sheet rich conformation as determined by CD, and bind ANS strongly, and these oligomers rapidly form dead-end protofilaments. However, under conditions in which the B chain monomer is present, such as low B chain concentration (<0.2 mg/mL) or in the presence of low concentrations of GuHCl, which dissociates the soluble oligomers, mature fibrils were formed. Thus, both A and B chain peptides can form amyloid fibrils, and both are likely to be involved in the interactions leading to the fibrillation of intact insulin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16866381     DOI: 10.1021/bi0604936

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

1.  Aggregates of α-chymotrypsinogen anneal to access more stable states.

Authors:  Ronald W Maurer; Alan K Hunter; Anne S Robinson; Christopher J Roberts
Journal:  Biotechnol Bioeng       Date:  2013-11-18       Impact factor: 4.530

2.  Modulation of self-association and subsequent fibril formation in an alanine-rich helical polypeptide.

Authors:  Ayben Top; Kristi L Kiick; Christopher J Roberts
Journal:  Biomacromolecules       Date:  2008-05-02       Impact factor: 6.988

3.  Sulfate anion delays the self-assembly of human insulin by modifying the aggregation pathway.

Authors:  Marta Owczarz; Paolo Arosio
Journal:  Biophys J       Date:  2014-07-01       Impact factor: 4.033

4.  Elucidating the locking mechanism of peptides onto growing amyloid fibrils through transition path sampling.

Authors:  Marieke Schor; Jocelyne Vreede; Peter G Bolhuis
Journal:  Biophys J       Date:  2012-09-19       Impact factor: 4.033

5.  Effect of homocysteine thiolactone on structure and aggregation propensity of bovine pancreatic insulin.

Authors:  Shima Jalili; Reza Yousefi; Mohammad-Mehdi Papari; Ali Akbar Moosavi-Movahedi
Journal:  Protein J       Date:  2011-06       Impact factor: 2.371

6.  Effects of dithiothreitol on the amyloid fibrillogenesis of hen egg-white lysozyme.

Authors:  Steven S-S Wang; Kuan-Nan Liu; Bo-Wei Wang
Journal:  Eur Biophys J       Date:  2010-02-07       Impact factor: 1.733

7.  Modulating Insulin Fibrillation Using Engineered B-Chains with Mutated C-Termini.

Authors:  Mohsen Akbarian; Reza Yousefi; Ali Akbar Moosavi-Movahedi; Atta Ahmad; Vladimir N Uversky
Journal:  Biophys J       Date:  2019-09-23       Impact factor: 4.033

8.  Supersaturation-limited and Unlimited Phase Transitions Compete to Produce the Pathway Complexity in Amyloid Fibrillation.

Authors:  Masayuki Adachi; Masatomo So; Kazumasa Sakurai; József Kardos; Yuji Goto
Journal:  J Biol Chem       Date:  2015-06-10       Impact factor: 5.157

9.  Molecular modeling of the misfolded insulin subunit and amyloid fibril.

Authors:  Jay H Choi; Barnaby C H May; Holger Wille; Fred E Cohen
Journal:  Biophys J       Date:  2009-12-16       Impact factor: 4.033

10.  Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.

Authors:  Michael P Kurnellas; Chris M Adams; Raymond A Sobel; Lawrence Steinman; Jonathan B Rothbard
Journal:  Sci Transl Med       Date:  2013-04-03       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.